% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Law:858413,
      author       = {Law, Ian and Albert, Nathalie L. and Arbizu, Javier and
                      Boellaard, Ronald and Drzezga, Alexander and Galldiks,
                      Norbert and la Fougère, Christian and Langen, Karl-Josef
                      and Lopci, Egesta and Lowe, Val and McConathy, Jonathan and
                      Quick, Harald H. and Sattler, Bernhard and Schuster, David
                      M. and Tonn, Jörg-Christian and Weller, Michael},
      title        = {{J}oint {EANM}/{EANO}/{RANO} practice guidelines/{SNMMI}
                      procedure standards for imaging of gliomas using {PET} with
                      radiolabelled amino acids and [18{F}]{FDG}: version 1.0},
      journal      = {European journal of nuclear medicine and molecular imaging},
      volume       = {46},
      number       = {3},
      issn         = {1619-7089},
      address      = {Heidelberg [u.a.]},
      publisher    = {Springer-Verl.},
      reportid     = {FZJ-2018-07297},
      pages        = {540–557},
      year         = {2019},
      abstract     = {These joint practice guidelines, or procedure standards,
                      were developed collaboratively by the European Association
                      of Nuclear Medicine (EANM), the Society of Nuclear Medicine
                      and Molecular Imaging (SNMMI), the European Association of
                      Neurooncology (EANO), and the working group for Response
                      Assessment in Neurooncology with PET (PET-RANO). Brain PET
                      imaging is being increasingly used to supplement MRI in the
                      clinical management of glioma. The aim of these
                      standards/guidelines is to assist nuclear medicine
                      practitioners in recommending, performing, interpreting and
                      reporting the results of brain PET imaging in patients with
                      glioma to achieve a high-quality imaging standard for PET
                      using FDG and the radiolabelled amino acids MET, FET and
                      FDOPA. This will help promote the appropriate use of PET
                      imaging and contribute to evidence-based medicine that may
                      improve the diagnostic impact of this technique in
                      neurooncological practice. The present document replaces a
                      former version of the guidelines published in 2006 (Vander
                      Borght et al. Eur J Nucl Med Mol Imaging. 33:1374–80,
                      2006), and supplements a recent evidence-based
                      recommendation by the PET-RANO working group and EANO on the
                      clinical use of PET imaging in patients with glioma (Albert
                      et al. Neuro Oncol. 18:1199–208, 2016). The information
                      provided should be taken in the context of local conditions
                      and regulations.},
      cin          = {INM-3 / INM-4},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-3-20090406 / I:(DE-Juel1)INM-4-20090406},
      pnm          = {572 - (Dys-)function and Plasticity (POF3-572)},
      pid          = {G:(DE-HGF)POF3-572},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:30519867},
      UT           = {WOS:000457151600003},
      doi          = {10.1007/s00259-018-4207-9},
      url          = {https://juser.fz-juelich.de/record/858413},
}